PTGX
Protagonist Therapeutics, Inc.
Stock
$140.06+0.87 (+0.63%)Close Oct 2, 2026
- Net income, 2025
- −$130M
Net income
Net income by fiscal year
| Period | Net income | YoY |
|---|---|---|
| 2025 | −$130M | — |
| 2024 | $275M | — |
| 2023 | −$79M | — |
| 2022 | −$127M | — |
| 2021 | −$126M | — |
| 2020 | −$66M | — |
| 2019 | −$77M | — |
| 2018 | −$39M | — |
| 2017 | −$37M | — |
| 2016 | −$37M | — |
| 2015 | −$15M | — |
| 2014 | −$11M | — |